Answers are grounded in this paper and cite their sources.
An IgM-class monoclonal antibody ( B36 ) [Greene, G. L., Fitch, F. W., & Jensen, E.V. (1980) Proc. Natl. Acad. Sci. U.S.A. 77, 157-161] raised against the calf uterine estrogen receptor (R) was used to probe the structure of R bound to estradiol or to 4-hydroxytamoxifen, a nonsteroidal anti-estrogen which displays a high affinity for R. This antibody does not noticeably modify the interaction of R with these ligands, but R, when bound to B36 , is markedly displaced in both low- and high-salt sucrose gradients. We found the following: The B36 antibody interacts more strongly with activated cytosol estradiol- and 4-hydroxytamoxifen-R complexes than with nonactivated (molybdate-stabilized) complexes. This antibody also interacts strongly with the nuclear forms of R bound to estradiol or to the anti-estrogen. The affinity of B36 for the nonactivated R-4-hydroxytamoxifen complex is 3-fold greater than for the non-activated R-estradiol complex. The difference is slightly less pronounced for activated complexes. Preincubation of activated R with saturating amounts of B36 partially (less than or equal to 60%) inhibits the binding of R-ligand complexes to DNA adsorbed onto cellulose. These results suggest that the B36 and DNA binding domains of R are related and strengthen the hypothesis that R has different external structures when activated or nonactivated and when bound to an anti-estrogen or to estradiol.
No takes yet. Share an insight, caveat, or question.
Borgna et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: